Costs and benefits of polio eradication: a long-run global perspective

被引:31
作者
Khan, MM
Ehreth, J
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA
[2] Aventis Pasteur, F-69367 Lyon, France
关键词
cost-effectiveness; medical care cost savings; DALYs;
D O I
10.1016/S0264-410X(02)00584-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pre-vaccination polio incidence rates in USA and Italy were used to predict the cases that would have occurred in the world for the years 1970-2050 in the absence of immunization. Globally, polio program will cost about S 67 billion if vaccination is discontinued after 2010. The medical care cost savings achieved will be more than $ 128 billions, implying that polio eradication activities actually pay for itself in the longer run. In addition to the cost savings, the program will prevent 855,000 deaths, 4 million paralysis cases and 40 million disability adjusted life years (DALYs) over the years 1970-2050. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:702 / 705
页数:4
相关论文
共 9 条
[1]  
Bart KJ, 1996, B WORLD HEALTH ORGAN, V74, P35
[2]   IMMUNIZATION PROGRAMS AND THEIR COSTS [J].
BRENZEL, L ;
CLAQUIN, P .
SOCIAL SCIENCE & MEDICINE, 1994, 39 (04) :527-536
[3]  
COCKBURN WC, 1970, B WORLD HEALTH ORGAN, V42, P405
[4]   EFFECT OF SABIN POLIOVIRUS VACCINE ON INCIDENCE OF POLIOMYELITIS IN ITALY [J].
GIOVANAR.A .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 209 (04) :525-&
[5]  
KADDAR M, 2000, COSTS FINANCING IMMU
[6]  
KHAN MM, 1998, 24 ABT ASS INC PARTN
[7]  
MUSGROVE P, 1989, SCI PUBLICATION PAHO, V517, P107
[8]  
Rong-Zhen Z, 1998, INT J HEALTH PLAN MA, V13, P5
[9]  
*US DEP COMM, 1970, SER US DEP COMM